Serigen Mediproducts: Financial Breakdown
Decoding financial health metrics of Serigen Mediproducts
Total Revenue₹21.0 Lakh23%Prev. FY
Total Expenses₹2.1 Cr73%Prev. FY
Profit After Tax₹-1.9 Cr-89%Prev. FY
Total Assets₹5.1 Cr-23%Prev. FY
Net Profit Margin-9.3%-50%Prev. FY
FAQs on Financials of Serigen Mediproducts
No. In FY24, Serigen Mediproducts reported a net loss of ₹1.9 Cr, so it was not profitable.
Serigen Mediproducts's revenue grew 23.5% year-on-year, from ₹17.0 Lakh in FY23 to ₹21.0 Lakh in FY24.
Serigen Mediproducts's estimated EBITDA for FY24 was ₹-1.9 Cr, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY24, Serigen Mediproducts posted revenue of ₹21.0 Lakh (up 23.5% YoY) and a net loss of ₹1.9 Cr. Explore the full financials of Serigen Mediproducts here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links